Miyaoka, T., Wake, R., Furuya, M., Liaury, K., Ieda, M., Kawakami, K., . . . Horiguchi, J. (2012). Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger’s disorder: A 12-week prospective, open-label study. BioMed Central.
استشهاد بنمط شيكاغوMiyaoka, Tsuyoshi, Rei Wake, Motohide Furuya, Kristian Liaury, Masa Ieda, Kazunori Kawakami, Keiko Tsuchie, Takuji Inagaki, و Jun Horiguchi. Yokukansan (TJ-54) for Treatment of Pervasive Developmental Disorder Not Otherwise Specified and Asperger’s Disorder: A 12-week Prospective, Open-label Study. BioMed Central, 2012.
MLA استشهادMiyaoka, Tsuyoshi, et al. Yokukansan (TJ-54) for Treatment of Pervasive Developmental Disorder Not Otherwise Specified and Asperger’s Disorder: A 12-week Prospective, Open-label Study. BioMed Central, 2012.